PHYTOMEDICINE 润色咨询

PHYTOMEDICINE

出版年份:1994 年文章数:2603 投稿命中率: 开通期刊会员,数据随心看

出版周期:Monthly 自引率:2.2% 审稿周期: 开通期刊会员,数据随心看

前往期刊查询

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:返修回去一个多月了,还是在邀请审稿人,难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药<br>经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161515, encodeId=c19f2161515a5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药抗肿瘤<br>经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Sun Oct 08 11:32:31 CST 2023, time=2023-10-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197546, encodeId=6fd1219e54687, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方<br>经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Tue Apr 09 10:23:45 CST 2024, time=2024-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省)]
    2024-03-25 ms2000000315947498 来自四川省

    1.02投稿,现在还在under review...一点消息无。等的心焦

    5

    展开5条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:返修回去一个多月了,还是在邀请审稿人,难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药<br>经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161515, encodeId=c19f2161515a5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药抗肿瘤<br>经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Sun Oct 08 11:32:31 CST 2023, time=2023-10-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197546, encodeId=6fd1219e54687, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方<br>经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Tue Apr 09 10:23:45 CST 2024, time=2024-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省)]
    2024-04-17 ms8000001467150727 来自北京

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:肾脏病;中药复方
    经验分享:返修回去一个多月了,还是在邀请审稿人,难受

    3

    展开3条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:返修回去一个多月了,还是在邀请审稿人,难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药<br>经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161515, encodeId=c19f2161515a5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药抗肿瘤<br>经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Sun Oct 08 11:32:31 CST 2023, time=2023-10-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197546, encodeId=6fd1219e54687, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方<br>经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Tue Apr 09 10:23:45 CST 2024, time=2024-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省)]
    2023-12-28 samtol 来自浙江省

    让我修了两轮的格式和图片
    12.25 submitted to journal
    12.26 under editor assessment

    26

    展开26条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:返修回去一个多月了,还是在邀请审稿人,难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药<br>经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161515, encodeId=c19f2161515a5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药抗肿瘤<br>经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Sun Oct 08 11:32:31 CST 2023, time=2023-10-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197546, encodeId=6fd1219e54687, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方<br>经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Tue Apr 09 10:23:45 CST 2024, time=2024-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省)]
    2023-03-27 ms4000000742058182 来自北京

    审稿速度:12.0 | 投稿命中率:50.0
    偏重的研究方向:中药
    经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?

    4

    展开4条回复
  5. [GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:返修回去一个多月了,还是在邀请审稿人,难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药<br>经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161515, encodeId=c19f2161515a5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药抗肿瘤<br>经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Sun Oct 08 11:32:31 CST 2023, time=2023-10-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197546, encodeId=6fd1219e54687, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方<br>经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Tue Apr 09 10:23:45 CST 2024, time=2024-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省)]
    2024-04-15 ms6000000634273240 来自四川省

    请问proof返回后大概多久online啊,已经大半个月了还没有online🥹

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:返修回去一个多月了,还是在邀请审稿人,难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药<br>经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161515, encodeId=c19f2161515a5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药抗肿瘤<br>经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Sun Oct 08 11:32:31 CST 2023, time=2023-10-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197546, encodeId=6fd1219e54687, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方<br>经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Tue Apr 09 10:23:45 CST 2024, time=2024-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省)]
    2023-05-26 ms6000000954293507 来自北京

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:肾脏病;中药复方
    经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?

    2

    展开2条回复
  7. [GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:返修回去一个多月了,还是在邀请审稿人,难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药<br>经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161515, encodeId=c19f2161515a5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药抗肿瘤<br>经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Sun Oct 08 11:32:31 CST 2023, time=2023-10-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197546, encodeId=6fd1219e54687, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方<br>经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Tue Apr 09 10:23:45 CST 2024, time=2024-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省)]
    2023-10-08 ms5000000155404164 来自吉林省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:中药抗肿瘤
    经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件

    5

    展开5条回复
  8. [GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:返修回去一个多月了,还是在邀请审稿人,难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药<br>经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161515, encodeId=c19f2161515a5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药抗肿瘤<br>经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Sun Oct 08 11:32:31 CST 2023, time=2023-10-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197546, encodeId=6fd1219e54687, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方<br>经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Tue Apr 09 10:23:45 CST 2024, time=2024-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省)]
    2022-08-10 msyukira

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:中药药理;中药复方
    经验分享:5.30投稿
    5.31要求提供缩略词,补充后当晚提交了
    6.6 under review
    6.22 Required Reviews Completed
    6.26 revise
    主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……
    7.14 summit
    7.15 Under Editor Assessment
    7.24 under review
    8.2 Required Reviews Completed
    8.3 Decision in Process
    8.4 accepted
    8.6 Proof

    感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下

    6

    展开6条回复
  9. [GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:返修回去一个多月了,还是在邀请审稿人,难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药<br>经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161515, encodeId=c19f2161515a5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药抗肿瘤<br>经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Sun Oct 08 11:32:31 CST 2023, time=2023-10-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197546, encodeId=6fd1219e54687, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方<br>经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Tue Apr 09 10:23:45 CST 2024, time=2024-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省)]
    2024-04-09 ms8000002041881019 来自北京

    审稿速度:3.0 | 投稿命中率:50.0
    偏重的研究方向:中药复方
    经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办

    0

  10. [GetPortalCommentsPageByObjectIdResponse(id=2195245, encodeId=5a9d2195245ff, content=1.02投稿,现在还在under review...一点消息无。等的心焦, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=11, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=26465474991, createdName=ms2000000315947498, createdTime=Mon Mar 25 16:02:09 CST 2024, time=2024-03-25, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2198942, encodeId=0763219894231, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:返修回去一个多月了,还是在邀请审稿人,难受, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=1, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f22a5486325, createdName=ms8000001467150727, createdTime=Wed Apr 17 12:43:58 CST 2024, time=2024-04-17, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2177803, encodeId=19a121e7803be, content=让我修了两轮的格式和图片<br>12.25 submitted to journal<br>12.26 under editor assessment, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=33, replyNumber=26, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20240101/570c45f5d7f2451da2e0a51a7b25b479/824b9aa7cdc24982879c3db6cbeb3798.jpg, createdBy=a3422257516, createdName=samtol, createdTime=Thu Dec 28 15:41:53 CST 2023, time=2023-12-28, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=2122040, encodeId=eb54212204091, content=审稿速度:12.0 | 投稿命中率:50.0<br>偏重的研究方向:中药<br>经验分享:想请问大家,Under Editor Assessment这个状态卡了快一个月了,是什么意思呀,可以发邮件催一下吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=51, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4fc65556145, createdName=ms4000000742058182, createdTime=Mon Mar 27 11:02:07 CST 2023, time=2023-03-27, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2198636, encodeId=1943219863695, content=请问proof返回后大概多久online啊,已经大半个月了还没有online🥹, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=3c368992874, createdName=ms6000000634273240, createdTime=Mon Apr 15 17:05:20 CST 2024, time=2024-04-15, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2139117, encodeId=8f50213911ec7, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:肾脏病;中药复方<br>经验分享:请问Proof后多久才能出版呢,已经Proof两周了,没有动静,并且Pre-Online是未Proof版本,上周已邮件咨询过,回复是正在校稿,这快两周过去了,有知道情况的友友吗?, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=43, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=8eab8634806, createdName=ms6000000954293507, createdTime=Fri May 26 09:07:39 CST 2023, time=2023-05-26, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2161515, encodeId=c19f2161515a5, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药抗肿瘤<br>经验分享:一审速度比较快,5月投稿,6月收到修改意见,二审、三审速度就非常慢!7月26号根据一审意见返回杂志社,9月18号返回二审意见,只有修改题目一条意见,19号修回后,26号才发邮件告知修改格式,当天修改完提交后,等到10月4日才显示状态改变,10月5日变成under review,发出2个review invitations,1个accept。。。真是太漫长了,感觉编辑1周处理一次稿件, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=35, replyNumber=5, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=63b45479551, createdName=ms5000000155404164, createdTime=Sun Oct 08 11:32:31 CST 2023, time=2023-10-08, status=1, ipAttribution=吉林省), GetPortalCommentsPageByObjectIdResponse(id=1237955, encodeId=4429123e9555f, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药药理;中药复方<br>经验分享:5.30投稿<br>5.31要求提供缩略词,补充后当晚提交了<br>6.6 under review<br>6.22 Required Reviews Completed<br>6.26 revise<br>主编+6个审稿专家,加起来50多个问题,审稿意见非常细节,很注重创新性。还好整体评价比较积极,对文章大框架没什么意见,只给了我3周修改,我还补了一点实验,最后几天写回复写到怀疑人生……<br>7.14 summit<br>7.15 Under Editor Assessment<br>7.24 under review<br>8.2 Required Reviews Completed<br>8.3 Decision in Process<br>8.4 accepted<br>8.6 Proof<br><br>感谢主编和外审专家们!第一次投sci,好多地方都不清楚,每天都快把论坛翻烂了……还好最后顺利接收,写一点我在翻帖子时大家提问多的事情吧:1.Author Agreement:这个在爱思唯尔投稿作者须知那里有个链接能下载,有点不太好找。2.western结果:revise时要求提供原始未裁剪的膜,这个前期做实验的时候需要注意下, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=feb46571516, createdName=msyukira, createdTime=Wed Aug 10 23:59:55 CST 2022, time=2022-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2197546, encodeId=6fd1219e54687, content=审稿速度:3.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方<br>经验分享:想问一下各位已投稿的宝子们phytomedicine复方投稿需要提供指纹图谱吗,没有怎么办, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=10, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=468e9243712, createdName=ms8000002041881019, createdTime=Tue Apr 09 10:23:45 CST 2024, time=2024-04-09, status=1, ipAttribution=北京), GetPortalCommentsPageByObjectIdResponse(id=2126674, encodeId=3a3521266e454, content=审稿速度:6.0 | 投稿命中率:50.0<br>偏重的研究方向:中药复方;代谢病<br>经验分享:2023.02.25 submit<br>2023.03.03 under editor assessment<br>2023.03.09 under review<br>2023.03.19 required reviews completed<br>2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。<br>2023.04.12 返回<br>2023.04.17 under editor assessment<br>2023.04.18 reviewer invited<br>目前是这种状态,后续再更新状态。<br><br>希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。<br>编辑和杂志都不错,效率其实还行。<br><br>希望能赶在毕业前接收~, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=87, replyNumber=20, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=54158562904, createdName=ms2000000770833142, createdTime=Tue Apr 18 09:45:29 CST 2023, time=2023-04-18, status=1, ipAttribution=广东省)]
    2023-04-18 ms2000000770833142 来自广东省

    审稿速度:6.0 | 投稿命中率:50.0
    偏重的研究方向:中药复方;代谢病
    经验分享:2023.02.25 submit
    2023.03.03 under editor assessment
    2023.03.09 under review
    2023.03.19 required reviews completed
    2023.03.25 revise,审稿人意见都比较积极,算是小修、润色、降重。给了20天修回。
    2023.04.12 返回
    2023.04.17 under editor assessment
    2023.04.18 reviewer invited
    目前是这种状态,后续再更新状态。

    希望能够顺利接收,总体来讲,审稿人如果审的快的话一个月就可以完成。
    编辑和杂志都不错,效率其实还行。

    希望能赶在毕业前接收~

    20

    展开20条回复
共500条页码: 1/50页10条/页
分享您的投稿经验,提升MI经验值,获取更多积分